Evidence map›Paper›PMID 32476907›Full record

ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2018

A 12-week combination of clarithromycin and prednisone compared to a 24-week prednisone alone treatment in cryptogenic and radiation-induced organizing pneumonia.

Nicolas Petitpierre, Vincent Cottin, Sylvain Marchand-Adam, Sandrine Hirschi, Dominique Rigaud, Isabelle Court-Fortune, Stéphane Jouneau, Dominique Israël-Biet, Anita Molard, Jean-François Cordier and 2 more

Open access · greenAbstract read
In one paragraph

Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. High-doseThe European respiratory journal · 2022
    Trial
  2. Article
  3. Update on cryptogenic organizing pneumonia.Frontiers in medicine · 2023
    Review
  4. Clarithromycin in Post COVID-19 Organizing pneumonia.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Nicolas PetitpierreInterstitial and rare lung diseases Unit, Department of Respiratory Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Vincent CottinDepartment of Respiratory Medicine and Reference Center for rare lung diseases, Lyon University Hospital, Lyon, France.
Sylvain Marchand-AdamDepartment of Respiratory Medicine, Tours University Hospital, Tours, France.
Sandrine HirschiDepartment of Respiratory Medicine, Strasbourg University Hospital, Strasbourg, France.
Dominique RigaudRespiratory physician, Private practice, Grenoble, France.
Isabelle Court-FortuneDepartment of Respiratory Medicine, St-Etienne University Hospital, St-Etienne, France.
Stéphane JouneauDepartment of Respiratory Medicine, Competences center for rare pulmonary diseases, IRSET UMR 1085, Rennes 1 University, Rennes University Hospital, Rennes, France.
Dominique Israël-BietDepartment of Respiratory Medicine, Georges-Pompidou European Hospital, Paris, France.
Anita MolardDepartment of Respiratory Medicine, Strasbourg University Hospital, Strasbourg, France.
Jean-François CordierDepartment of Respiratory Medicine and Reference Center for rare lung diseases, Lyon University Hospital, Lyon, France.
Romain LazorInterstitial and rare lung diseases Unit, Department of Respiratory Medicine, Lausanne University Hospital, Lausanne, Switzerland.
and the Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM”O”P)
Université de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clarithromycincryptogenic organizing pneumoniaglucocorticoidsinterstitiallung diseasesrecurrencetreatment outcome

Identifiers

PMID32476907
PMCPMC7170161
OpenAlexW3029747442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.